Skip to content

Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus

Variable Changes in Continuous Resting EEG(Electroencephalography) and Auditory ERP(Event-related Potential) Before and After Transcranial Magnetic Stimulation Treatment; Double Blind Randomized Controll Trails

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02617953
Enrollment
80
Registered
2015-12-01
Start date
2015-09-30
Completion date
2021-09-30
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

Tinnitus, EEG, ERP

Brief summary

Investigation of objective tinnitus diagnosis method through measurement of continuous resting EEG, auditory ERP before and after Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of tinnitus.

Detailed description

Tinnitus is defined as the subjective perception of a sound in the absence of any physical sound. Therefore, accurate diagnosis of tinnitus is so difficult. So, Investigators measure auditory ERP through autonomously developed system to make a objective diagnosis tinnitus. Moreover, patients undergo continuous resting EEG measurement. In this study investigators examined the efficacy of rTMS treatment for tinnitus and check into changes in brain connectivity or auditory task with ERP, continuous resting EEG before and after rTMS. And develop a new test that can detect tinnitus objectively in humans, using the prepulse gap paradigm

Interventions

DEVICEActive rTMS(A)

repetitive transcranial magnetic stimulation:1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex , each consisting of 4 days of rTMS treatment. auditory ERP,continuous resting EEG and MRI are measured pre-treatment rTMS and auditory ERP,continuous resting EEG are measured two weeks after rTMS treatment. Tinnitus subjects were asked to perform an interval duration paried pulse task before and after the rTMS train.

DEVICEActive rTMS(B)

repetitive transcranial magnetic stimulation:1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex , each consisting of 4 days of rTMS treatment. auditory ERP,continuous resting EEG and MRI are measured pre-treatment rTMS and auditory ERP,continuous resting EEG are measured two weeks after rTMS treatment. Tinnitus subjects were asked to perform an interval duration paried pulse task before and after the rTMS train.

DEVICESham condition(C)

The sham stimulation looks and sounds like the active coil, but diverts the magnetic field away from the patient. auditory ERP,continuous resting EEG and MRI are measured pre-treatment rTMS and auditory ERP,continuous resting EEG are measured two weeks after rTMS treatment. Tinnitus subjects were asked to perform an interval duration paried pulse task before and after the rTMS train.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of chronic tinnitus * Chronic subjective tinnitus for more than 6 months * Subject is naive regarding rTMS * Other concurrent treatments: A four-week washout from any other tinnitus treatment or management program is required prior to entering this study * Stable enough to complete this study per the opinion of the Study Physician * No restrictions, provided the dosages have been in place for at least 3 months * A three month washout from any other tinnitus treatment or management program is required prior to entering this study.

Exclusion criteria

* Objective tinnitus or tinnitus with treatable cause * Presence of intracranial or intraocular ferromagnetic materiel or particles * Cardiac pacemaker or other electronic implants (including cochlear implant) Serious heart disease or other unstable major medical condition * Personal history of central nervous system disorder, head injury, stroke or seizures * Familial history of epilepsy * Concomitant medication with antidepressants and antipsychotics * Pregnant women * Others known contraindications to rTMS or brain MRI

Design outcomes

Primary

MeasureTime frame
Change of Tinnitus Handicap Inventory (THI) before and after treatment , difference in brain gating and connectivity before and after treatment.Change from Baseline THI at 6 months

Secondary

MeasureTime frame
Change of Visual Analogue Scale (VAS) for tinnitus states before and after treatment.Change from Baseline VAS at 6 months
Positive And Negative Affect Schedule(PANAS)Baseline, 1, 2 and 3 month after the first intervention
Beck's Depression Inventory (BDI)Baseline
State-Trait Anxiety Inventory (STAI)Baseline
Pittsburgh Sleep Quality Index (PSQI)Baseline

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026